Steven X F Zheng (X F Steven Zheng)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Electronic Health Record

Small Cell Lung Cancer

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen K Burley, Amy Wu-Wu, Shuchismita Dutta, Shridar Ganesan, Steven X F Zheng
Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023. Oncogene 43 (29) (2024)
Stephen K Burley, Amy Wu-Wu, Shuchismita Dutta, Shridar Ganesan, Steven X F Zheng
Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023. Oncogene 43 (29) (2024)
Stephen K Burley, Amy Wu-Wu, Shuchismita Dutta, Shridar Ganesan, Steven X F Zheng
Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023. Oncogene 43 (29) (2024)
Stephen K Burley, Amy Wu-Wu, Shuchismita Dutta, Shridar Ganesan, Steven X F Zheng
Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023. Oncogene (2024)
Xiaowen Wang, Hong Zhang, Russell Sapio, Jun Yang, Justin Wong, Xin Zhang, Jessie Y Guo, Sharon R Pine, Holly Van Remmen, Hong Li, Eileen P White, Chen Liu, Megerditch Kiledjian, Dimitri G Pestov, Steven X F Zheng
SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nature communications 12 (1) (2021)